 |
Haloperidol Patient Selection. Patients with histologically confirmed advanced solid malignancies refractory to standard therapy or for whom no effective therapy existed were candidates for this study. Other eligibility criteria included: a ; age 18 years; b ; Eastern Cooperative Oncology Group performance status of 0 to ambulatory and capable of light work c ; life expectancy of at least 12 weeks; d ; presence of measurable or evaluable disease; e ; no known untreated brain metastases or history of a seizure disorder; f ; no chemotherapy, radiotherapy, or investigational agents in the previous 4 weeks; g ; no nitrosoureas or mitomycin C within the previous 6 weeks; h ; no prior highdose chemotherapy with stem cell rescue; i ; cumulative anthracycline dose not exceeding the equivalent of 450 mg m2 of doxorubicin; j ; no myocardial infarction, unstable angina, or congestive heart failure within the past 12 months; k ; adequate hematopoietic absolute neutrophil count 1, 500 l, platelet count 100, 000 l, and hemoglobin 9.0 g dl ; , hepatic total serum bilirubin 1.5 times the upper limit of normal, transaminases 2.5 times the upper limit of normal, and alkaline phosphatase 4 times the upper limit of normal ; , and renal serum creatinine concentration 1.5 times the upper limit of normal ; functions; l ; prothrombin and partial thromboplastin 1.2 times the upper limit of normal; m ; serum potassium, calcium, and magnesium within the normal range and other serum electrolytes within 10% of the normal range; n ; no history of significant cardiac dysrhythmias atrial fibrillation or grade 3 dysrhythmia ; or QTc abnormalities; o ; QTc 440 ms on screening ECG; p ; no concomitant use of medications with dysrhythmic potential including, but not limited to, terfenadine, astemizole, cisapride, diphenhydramine, quinidine, procainamide, disopyramide, sotalol, probucol, bepridil, tricyclic antidepressants, haloperidol, risperidone, and indapamide q ; no concomitant use of medications which induce CYP3A including, but not limited to, rifampin, phenobarbital, phenytoin, carbamazepine, troglitazone, and rifabutin, because L-778, 123 is primarily metabolized by CYP3A4 ; , or CYP3A-metabolized benzodiazepines, or 3-hydroxy-3-methylglutaryl acetyl-CoA reductase inhibitors; r ; no history of a significant retinal disorder or disease; and s ; no other coexisting medical problems of sufficient severity to prevent full compliance with the study. Females of childbearing age were required to be practicing effective contraceptive measures and to have had a negative serum pregnancy test before study entry. Written informed.
About us refills shipping information canadian pharmacies partners tell a friend miacalcin canadian pharmacy prices buy miacalcin canada drugs online home prescription drugs search view price quote how to order order form contact us faqs search rx · view price quote · complete drug list · drug index · how to order · order forms browse by a-z a our partner 20 popular drugs · accutane · provigil · haloperidol · vytorin · caduet · procarbazine · lyrica · atenolol · cephalexin · diovan · effexor · furosemide · lanoxin · lipitor · naproxen · paxil · premarin · prevacid · synthroid · trazodone · trazodone · wellbutrin sr · zithromax miacalcin buy miacalcin canada drugs online miacalcin spray calcitonin ; 200iu - 28 dose - brand price: 58 53 usd quantity: 1 ready to order.
Gerard, 'the one armed-man', uses haloperidol to control and suppress mike, his inhabiting spirit!
Drug-induced agranulocytosis in older people. A case series of 25 patients SIR--We retrospectively analysed 25 consecutive cases of drug-induced agranulocytosis in older patients in the departments of geriatrics, internal medicine, onco haematology and rheumatology of the Hopitaux Universitaires de Strasbourg a tertiary referral centre ; , between 1985 and 1997. Patients had to be 70 older and have unquestionable drug-induced agranulocytosis. All data were obtained from the patients' files, including medical history, clinical status on referral, relevant bacteriological and biochemical data, blood count and marrow examination when available ; . Treatment modalities, use of haematopoietic growth factors, length of time for the neutrophil count to reach 1.5 109 l and outcome were also recorded. The median age was 79 years range 7095 ; . The sex-ratio was 1.47, with a predominance of women. A single drug was implicated in 23 cases, whereas the causative agent was unclear in two cases Table 1 ; . Twenty-two patients ingested multiple drugs median 3 ; . A previously normal blood count was not established for all patients before diagnosis, so it is possible that other factors such as infection ; may have caused the agranulocytosis. Diagnosis was made fortuitously in six patients and 19 presented with various symptoms, septicaemia and septic shock being the most frequent. Six patients received haematopoietic growth factors for a mean of 7 days, but their recovery period did not differ from the other patients. The outcome was generally favourable, although two patients, aged 81 and 90 ; died of septic shock. A pathogen was found in 10 25 patients, with Staphylococcus epidermidis in three, Escherichia coli in two ; and Staphylococcus aureus, Micrococcus, Pseudomonas aeruginosa, Moraxella and Streptococcus D in one each. The annual incidence of drug-induced agranulocytosis varies between 2.4 and 15.4 cases year 106 in the USA and is 4.7 cases year 106 in Europe [1, 2]. Older.
This attitude is a reflection of brutal nazism in mental healthcare.
Ac existing ffprhc and rcog guidance ffprhc ceu guidance on drug interactions with hormonal contraception 4 states that rifampicin and rifabutin used in treatment of tuberculosis or meningococcal meningitis prophylaxis ; are potent liver enzyme inducers and indeed case series have identified pregnancies occurring in women using coc and rifampicin ; 6 the evidence to support rifampicin and rifabutin decreasing the efficacy of hormonal contraception is of poor quality and imodium.
In the original study by Soloff et al 1986 ; , amitriptyline was not helpful in the treatment of borderline personality disorder indeed, it was of less value than haloperidol even in the treatment of depression ; and its lack of value has become the accepted view. However, it is fair to note than there have been very few studies of tricyclic antidepressants in the treatment of personality disorder and none of the recent ones has included a tricyclic control. In a randomised trial of the treatment of common anxiety and depressive disorders that continued for 2 years after the formal trial was over, those allocated to the tricyclic antidepressant dothiepin had the same outcome irrespective of whether or not they had a personality disorder, whereas those allocated to psychological treatments self-help and cognitive behavioural therapy ; fared worse if they had.
General a number of cases of bronchopneumonia, some fatal, have followed the use of antipsychotic drugs, including haldol haloperidol and loperamide.
Talk to your health care professional about which form is best for you.
Australia imports more pharmaceuticals than it exports and indomethacin.
N2 neuraxpharm arzneimittel gmbh co kg haloperidol-neuraxpharm 20 50 tbl.
Advertised before Acceptance under section 20 1 ; Proviso 1198921 - May 14, 2003. JIVRAMBHAI JETHABHAI CHAUDHRI REENA RAJENDRAKUMAR JANI, trading as SERENE HEALTHCARE 4, GAURAV DIAMOND COMPLEX, MALGODOWN ROAD, MEHSANA - 384 002 , GUJARAT. MANUFACTURER & MERCHANT. Address for service in India Agents Address : D.C. DANI & ASSOCIATES. 11 A, LALBHAI APPARTMENT, NEAR RAILWAY CROSSING, KIRAN PARK, NAVA WADAJ, AHMEDABAD-380 013. User claimed since 06 11 2001 AHMEDABAD ; PHARMACEUTICALS AND MEDICINAL PREPARATIONS INCLUDED IN CLASS 5. REGISTRATION OF THIS TRADE MARK SHALL GIVE NO RIGHT TO THE EXCLUSIVE USE OF THE ALL DESCRIPTIVE WORDS AND MATTERS APPEARING ON THE LABEL and ismo.
Share in pharmacy sales, % Q1Q3 Q1Q3 2005 2004 5.0 Table 4. Top 10 ATC groups by sales value.
Cheap haloperidol
Therapeutic variation daily doses, by the oral via ; : haloperidol 1mg; orphenadrine 50mg; bromazepam 75mg; carbamazepine 100mg and monoket.
Although they are broader spectrum than is oxacillin, they do not classify as broad-spectrum drugs, and are perfectly acceptable for the routine treatment of canine pyoderma.
Dr. Paul Janssen 1926-2003 ; was one of the 20th century's most innovative and inspiring pharmaceutical researchers. His work was responsible for many breakthroughs in several fields of disease, including pain management, psychiatry, infectious disease and gastroenterology. Dr. Paul, as he was known throughout the global scientific community, was an exceptionally gifted and passionate scientist who revolutionized modern medicine and inspired a new generation of researchers. In 1953, Dr. Paul established Janssen Pharmaceutica, a pharmaceutical research laboratory based in Beerse, Belgium. In Beerse, he laid the foundation for more than 80 medicines that have saved millions of lives. One such medicine, HALDOL haloperidol ; , was the first antipsychotic therapy that allowed patients to be treated at home. Prior to HALDOL, the only treatments for psychosis were associated with crippling side-effects. Even today, HALDOL continues to be used for the management of psychosis. Dr. Paul also worked on the development of FENTANYL, the most widely used anesthetic worldwide, and REASEC, diphenoxylate ; , used for the treatment of diarrhea, which had been a disabling and sometimes fatal disease in developing countries. Janssen Pharmaceutica, became part of Johnson & Johnson in 1961. Throughout Dr. Paul's lifetime, he received many awards, including five honorary professorships and 22 honorary doctorates. He was author or co-author of more than 850 scientific publications and was honorary member of over 30 scientific institutes and organizations. Furthermore, he has more than 100 patents to his name and imdur.
DIHYDROQUINIDINE HALOPERIDOL HALOPERIDOL OXAZEPAM OXAZEPAM MESORIDAZINE OXAZEPAM TIAPRIDE OXAZEPAM ANTIARTERIOSCLEROTICS SEROSA SEROSITIS SEROTHERAPY SEROTONIN SEROTONIN-1 SEROTONIN-1A SEROTONIN-1B SEROTONIN-1C PROTOZOACIDES ANTISEROTONINS LY-281067 SEROTONIN-1D SEROTONIN-2 SEROTONIN-3 SEROTONIN-4 ANTIINFLAMMATORIES VULNERARIES VULNERARIES ANTIINFLAMMATORIES PMSG serotonin-antagonist serotonin-creatine-sulfate SEROTONIN-CREATININE-SULFATE SEROTONIN-M BRONCHODILATORS ANTIANAPHYLACTICS LEUKOTRIENE-ANTAGONISTS SEROTONIN-RECEPTOR SEROTONIN-TRANSPORTER SEROTONINERGIC use was PHOSPHOSERINE SERINE-PHOSPHATE SEROTONINERGICS * SEROTROPIN SEROTYPE SEROTYPING SEROUS use COSMOCARCIN-A * SERPASIL * SERPASOL FLUDROXYCORTIDE h.t. ANTIINFLAMMATORIES NICERGOLINE SERPENTINE SERPIGINOUS SERPULINA h.t. h.t. note use use h.t. h.t. SEROQUEL h.t.
Buy cheap haloperidol online
Neuroleptic Malignant Syndrome Incidence: About 0.2% of patients Timing: Usually in the first 30 days of therapy Risk factors Rapid neuroleptization Haloperidol Lithium Previous reaction Pathophysiology Blockade of dopaminergic receptors in the corpus striatum Clinicial Spasticity of the skeletal muscle that generates excessive heat. Impaired hypothalamic thermoregulation that leads to autonomic dysfunction that impairs heat dissipation. Diagnosis Drug history Hyperthermia Muscle rigidity "lead pipe" Altered mental status Autonomic instability CPK elevation Treatment: Rapid cooling Sedation benzodiazepines ; May require neuromuscular blockade Volume resuscitation Limited role for: Bromocriptine Dantrolene and sorbitrate.
Antipsychotics Antipsychotics have limited evidence of efficacy and many adverse effects in anxiety. They are occasionally used at low doses for their sedative and calming effects. Many of the older, typical, antipsychotics eg, chlorpromazine, haloperidol and trifluoperazine, are licensed for use in the short-term management of severe anxiety. Movement disorders such as akathisia are generally more common with the typical antipsychotics, making assessment of agitation in anxiety more difficult. In addition, antipsychotic-induced akathisia has been associated with suicidal behaviour.5 The newer, atypical antipsychotics are less likely to cause movement disorders. Of these, olanzapine has been proven useful in social phobia and post-traumatic stress disorder PTSD ; 2, 3, risperidone in PTSD and obsessive-compulsive disorder OCD ; 2 and quetiapine in OCD.2 In general antipsychotics are used after the failure of conventional treatments and usually in combination with an antidepressant. NICE states that antipsychotics should not be prescribed for panic disorders.4.
Halog .21 haloperidol .16 HCTZ .6-7 Hectorol .9 Hepsera.14 Hiprex see methenamine Hivid .14 homatropine .12 homotropine .12 HS 11 Humalog pen .8 Humalog vial .8 human insulin Humulin pen ; .8 human insulin Humulin vial ; .8 human insulin Novolin pen ; .8 Humatin .14 Humatrope .11 Humibid LA see guiafenesin XR Humira .16 Humulin pen .8 Humulin vial .8 hydralazine .7 hydralazine HCTZ.7 hydralazine reserpine.7 Hydra-Zide see hydralzine HCTZ Hydrea see hydroxyurea hydrochlorothiazide .7 hydrochlorothiazide HCTZ ; .7 hydrocodone .19 hydrocortisone .12-13, 15, 20, hydrocortisone Rx only ; .20 hydrocortisone rectal .22 hydrocortisone neomycin .12 hydrocortisone neomycin polymyxin .12 hydrocortisone neomycin polymyxin Cortisporin ; .12 hydrocortisone polymyxin neomycin .13 hydrocortisone polymyxin neomycin Cortisporin Otic, Octicair ; .13 Hydrocortone see hydrocortisone hydromorphone .19 hydroxyamphetamine tropicamide .12 hydroxyamphetamine tropicamide Paremyd ; .12 hydroxychloroquine.14-15 hydroxyurea.15 hydroxyzine .22 Hygroton see chlorthalidone hyoscyamine .22 hyoscyamine generic, Anaspaz ; .22 hyoscyamine NuLev ; .22 Hytrin see terazosin Hyzaar.6 ibandronate Boniva ; .9 ibuprofen .18-19 and imipramine.
Note: C Caucasian; AA African American; H Hispanic; T typical antipsychotic; A patient was unavailable. a Percentage of homework completed. b Higher SDS Sheehan Disability Scale ; scores represent greater disability. c Patient in double-blind haloperidol vs. risperidone ; study.
DGPA ACCUMULATION IN MEDIAN EMINENCE: AN INDEX OF TUBEROINFUNDIBULAR DOPAMINERGIC NERVE ACTIVITY. K.T. Demarest * and K 2. Moore. Dept. of Pharmacology and Toxicology, Michigan State University, East Lansinq, MI 48824. Changes in the-rate of accumulation of DOPA in the striatum ST ; following the administration of a decarboxylase inhibitor have been used to estimate changes in the activity of nigrostriatal dopamine DA ; nerves. The development of a radioenzymatic assay for DOPA has now permitted the use of this technique to estimate the activity of tuberoinfundibular DA nerves which terminate in the median eminence ME ; . In the present studies the concentrations of DOPA in ME and ST were determined 30 min after the administration of 3-hydroxybenzylhydrazine 100 mg kg, i.p. ; , a centrally active inhibitor of DOPA decarboxylase. Haloperidol 2.5 mg kg, i.p. ; , a DA antagonist, markedly increased DOPA accumulation in the ST at 2 while a similar increase in the ME was not observed until 16 hr. Estradiol benzoate 25 pg kg day x 3, z.c. ; increased DOPA accumulation in ME but not in ST. These results are consistent with previous findings utilizing the rate of decline of DA after a-methyltyrosine to estimate DA turnover. Haloperidol and estradiol-induced increases of DOPA accumulation in ME appear to be secondary to increases in serum prolactin concentrations since they are not seen in hypophysectomized rats. These results support the proposal that tuberoinfundibular DA nerves are regulated, in part, by circulating levels of prolactin. Supported by NIH grant NE 09174 and Fellowship NS 06026 and tofranil and haloperidol.
Medical questions and answers by a neurosurgeon and family doctor.
Bottom line: find a doctor and a pharmacist you really trust and before you pay for some expensive new drug, find out what it does and if there are other drugs that are chemically equivalent but cheaper and indapamide.
Bromocriptine as Adjunctive Therapy to Clozapine in Treatment-Resistant Schizophrenia Dear Sir: Frontal lobe dysfunction is widely suspected to underlie negative symptoms of schizophrenia 1 ; . There is a possible correlation between hypodopaminergic function in the prefrontal cortex and negative symptoms of schizophrenia. The antidopaminergic effect of typical neuroleptics in the frontal lobe has been considered a causal factor for neurolepticinduced deficit syndrome 2 ; . By contrast, the superiority of clozapine in the treatment of negative symptoms has been partially explained by its ability to enhance the dopamine release from neurons projecting to the prefrontal cortex 3 ; . Studies evaluating the use of dopamine agonists in the treatment of schizophrenia have shown some efficacy for these drugs. Some patients have shown improvement after coadministration of dextroamphetamine and haloperidol 4 ; , for example. Further support is derived from a strong correlation between the level of dopamine metabolite in the cerebrospinal fluid and the prefrontal activity during Wisconsin Card Sorting Test performance 5 ; . To the best of my knowledge, no previous study or report has been published to evaluate the effects of coadministration of dopamine agonist with clozapine in the management of treatment-resistant schizophrenic patients. I wish to report on a patient who demonstrated a rapid and significant improvement of negative symptoms in response to the addition of bromocriptine to treat pituitary adenoma ; after 6 months of unsuccessful treatment with clozapine. A 42-year-old woman had been physically and mentally well until the age of 22, when she developed symptoms suggestive of schizophrenia, undifferentiated type. She had been frequently admitted to the hospital for adjustment of medication. Her pharmacotherapy trial was typical--lithium augmentation and benzodiazepine agents--but the improvement was limited to the positive symptoms. For this reason, a regimen of clozapine was started 600 mg divided doses ; despite adjuvant selective serotonin reuptake inhibitor SSRI ; fluoxetine 20 mg daily ; . The patient completed the first 6 months on this regimen with minimal or no changes and started to experience galactorrhea and amenorrhea during the latter part of clozapine trial. Serum prolactin level was 190 mg L. Magnetic resonance imaging showed an enlarged sella turcica and small, asymmetrical soft tissue enlargement with no suprasellar extension. There were no other intracranial abnormalities. She was diagnosed as having a case of pituitary adenoma. Treatment for the pituitary adenoma was started with bromocriptine at 2.5 mg bid and increased to 5 mg bid after.
Ethical dilemmas for nurses was A. feelings of isolation B. inadequate information to make a decision C. other health care professionals making decisions for nurses D. avoidance of ethical dilemmas.
Risperidone, haloperidol and pimozide have been found to significantly reduce the severity and frequency of tics, but there are side effects. Although pimozide is less sedating than haloperidol, it has a greater risk of ECG abnormalities. 1b ; Clonidine has been shown to significantly reduce the number and severity of motor tics, but it demonstrates no improvement in vocal tics. 1b.
Otherwise it is like taking a pill, just to spit it out.
Ergotamine Tartrate, Belladonna Alkaloids and Phenobarbital Errin Erythromycin Erythromycin Ethylsuccinate Erythromycin Stearate Erythromycin with Benzoyl Peroxide Estradiol Patch 0.05, 0.1mg QL Estropipate Etodolac Fast Take Test Strips QL, DS Felodipine Flecainide Fluconazole 50, 100, 200mg N Fluconazole 150mg QL Fludrocortisone Fluocinolone Fluocinonide Fluocinonide-E Fluorometholone Fluoxetine QL Flurazepam Flurbiprofen Fluvoxamine QL Folic Acid Freestyle Test Strips QL, DS Furosemide Gabapentin Capsule, Tablet Gemfibrozil Gentamicin Glimepiride Glipizide Glipizide Extended-Release Glyburide Glyburide Micronized Guanfacine Halobetasol Cream, Ointment Haloperidol Hydralazine Hydrochlorothiazide Hydrocodone with Homatropine Hydrocortisone Acetate Suppositories Hydrocortisone Valerate Hydromorphone Hydroxychloroquine Hydroxyzine Ibuprofen - Prescription strengths only Ibuprofen with Hydrocodone Imipramine Indapamide Indomethacin Ipratropium Inhalation Solution Isometheptene, Dichloralphenazone and Acetaminophen Isoniazid Isosorbide Dinitrate Isosorbide Mononitrate Itraconazole QL, N Junel Junel FE Kariva Ketoconazole Ketoprofen Ketorolac Labetalol Lactulose Leflunomide QL Lessina Levothyroxine Levora-28 Lidocaine Viscous Lisinopril Lisinopril with Hydrochlorothiazide Lithium Carbonate Lithium Carbonate Controlled-Release Lithium Carbonate Extended-Release Lorazepam Lovastatin QL QD Low-Ogestrel Mebendazole Medroxyprogesterone Mefloquine Megestrol Meperidine Meperidine with Promethazine Mesalamine Enema Metformin Metformin Extended-Release Methadone Methimazole Methocarbamol Methotrexate Methyldopa Methylphenidate Methylphenidate Extended-Release Methylprednisolone Methyltestosterone with Esterfied Estrogens Metoclopramide Metolazone Metoprolol Metronidazole Metronidazole Cream Microgestin Microgestin FE Minoxidil Tablet Mirtazapine QL Mirtazapine Dispersible Tablet QL Misoprostol Mometasone Cream, Ointment Mononessa Morphine Mupirocin Ointment Nadolol Naproxen - Prescription strengths only Necon Nefazodone QL Neomycin Polymyxin B Dexamethasone Neomycin Polymyxin Gramicidin Neomycin Polymyxin Hydrocortisone Nifedipine Nifedipine Controlled-Release Nifedipine Extended Release Nitrofurantoin Nitrofurantoin Macrocrystals Nitrofurantoin Macrocrystals Nitroglycerin Norethindrone Nortrel Nortriptyline Novolin Vials Novolog Vials and imodium.
Zodiazepine which may in fact worsen confusion. If sedation is desired, a logical alternate neuroleptic is thorazine. Either medication may be given orally or rectally. Please order either haldol or thorazine for your patient's kit, not both. For excessive secretions, atropine drops are standard if clear mental status is not a priority as is often the case as the patient slips into coma on the road to death. For the elderly patient who is not actively dying and who is prone to delirium, robinul may be a better alternative because it does not cross the blood-brain barrier and contribute to delirium. Nausea and vomiting may also be treated acutely with haloperidol orally or rectally. This dopamine antagonist is particularly useful as a CTZ antagonist in patients who are not currently receiving an anti-emetic. For those likely to develop complicated nausea and vomiting due to multiple mechanisms, however, a combination suppository of benadryl, reglan, and dexamethasone which counteracts and covers all five mechanisms involved in nausea and vomiting ; is preferred, particularly in those not already receiving combination anti-emetic therapy. Anxiety and seizures may be controlled with valium orally, sublingually, or rectally as required by the level of consciousness of the patient. The afore-mentioned symptoms are the most common we deal with emergently. In the months that the kits have been available in the program, they have been used on multiple occasions to effectively manage symptoms emergently. We have learned a few caveats in ordering the kits and wish to share them with you now. Please order only one medication from each category to be included in the individualized kit. Also, not all medications need be ordered for every patient. Kits are to be individualized based on likely patient need in anticipation of problems based on diagnosis and prognosis. The hospice nurse can be very helpful in suggesting specific medications for the patient's individualized kits. Medication that is already available in the home need not be duplicated in the kit. Most kits should be ordered at the time of admission, particularly if the patient has an extremely limited prognosis.
| 1. And~n, N. E., S. G. Butcher, H. Corrodi, K. Fuxe and U. Ungerstedt. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur. J. Pharmac. I1: 303-314, 1970. 2. Anlezark, G. M., G. W. Arbuthnott, J. E. Christie and T. J. ; row. Electrical self-stimulation with electrodes in the region of the interpeduncular nucleus. J. PhysioL, Lond. 234: 103 P, 1973. 3. Burton, M. J., E. T. Rolls, t: . Mora and S. J. Cooper. Ncurophysiological mapping of self-stimulation pathways in the monkey. in preparation ; . 4. Crow, T. J. A map of the rat mesencephalon for electrical sclfistimulation. Brain Res. 36: 265-273, 1972. Emmers, A. and K. Akert. A Stereotaxic Atlas o]the Bra o f the Squirrel Monkey. Madison: The University of Wisconsin Press, 1963. 6. Kelly, P. H., IL T. Rolls and S. G. Shaw. Functions of catccbolamines in brain-stimulation reward. Brain Res. 36: 363 364, leonard, C. M. The prefrontal cortex in the rat. i. Cortical projections of the mediodorsal nucleus. I1. Efferent connections. Brain Res. 1 2 : 1969. 8. Mora, F., A. M. Sanguinetti, E. T. Rolls and S. ; . Shaw. Differential effects on self-stimulation and motor behaviour produced by microintracranial injections of a dopamine-receptor blocking agent. Neuroscience Letters I : 179- 184, 1975. I. 12. 13. RolLs, E. T. The neural basis of brain-stimulation reward. Progress in Neurobiology 3: 71-160, 1974. Rolls, E. T. and S. J. Cooper. Anesthetization and stimulation of the sulcal prefrontal cortex and brain-stimulation reward. Physiol. Behav. 12: 563-571, 1974. Rolls, E. T. 7"he Brain and Reward. London: Pergamon Press, 1975. Rolls, E. T., P. H. Kelly and S. G. Shaw. Noradrenaline, dopamine, and brain-stimulation reward. Pharmac. Biochem. Behav. 2: 735-740, 1974. Rolls, E. T., B. J. Rolls, P. H. Kelly, S. G. Shaw, R. J. Wood and R. Dale. The relative attenuation of self-stimulation, eating and drinking produced by dopamine-receptor blockade. Psychopharmacologia 3 8 : 1974. Snider, R. S. and J. C. Lee. A Stereotaxicatlas o]'the monkey brain Macaca mulatta ; . Chicago: University of Chicago Press, 1961. Thierry, A. M., J. P. Tassin, G. Blanc and J. Glowinski. Topographic and pharmacological study of the dopaminergic mesocortical system. In: Brain-stimulation Reward, edited by A. Wauquier and E. T. Rolls. Amsterdam: North-Holland, 1976. Wauquier, A. and C. J. E. Niemegeers. lntracranial self-stimulation in rats as a function of various stimulus parameters. II. lnlluence of haloperidol, pimozide and pipamperone on medial forebrain stimulation with monopolar electrodes. Psychopharmacologia 27: t 91 --202, 1972.
That it should be considered as one of the treatment options in acute mania.9 Similarly, quetiapine received a licence for acute mania after publication of the NICE guidance on newer treatments for mania and there is also clinical trial evidence to support its use for this indication.10, 11 Risperidone has demonstrated efficacy comparable with that of haloperidol in acute mania12 but it is not as yet licensed in the UK for this indication. In patients maintained on mood stabilising drugs who develop symptoms of mania, the mood stabiliser dose should be optimised before the antipsychotic drug is added as treatment. Anticonvulsant drugs Studies have shown valproic acid mainly as semisodium valproate ; to be effective in treating acute mania.13, 14 Rapid dose titration is necessary for optimal antimanic effect. Carbamazepine has also been studied, but it is not licensed for acute mania and is rarely used as a first line treatment.15 Lithium There is limited evidence to support the use of lithium as monotherapy in acute mania, although it may be a feasible option in less severe forms of mania for patients who are maintained on lithium as a prophylactic treatment.16 See "prophylactic drugs" below for further information about using lithium. ; Benzodiazepines Evidence supports the use of benzodiazepines usually lorazepam in the UK ; as adjunctive treatments, given parenterally if necessary, in patients with mania who are particularly agitated.4.
|
| |
|
